Can withholding therapy against patients' wishes be ethical?;Ist ein Therapieverzicht gegen den Willen des Patienten ethisch begründbar?

Ethik in der Medizin

Volumn 22, Issue 2, 2010, Pages 89-102

  Winkler, Eva C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

End of life decision making; Medical futility; Shared decision making; Withholding treatment

Indexed keywords

EID: 77953022622     PISSN: 09357335     EISSN: 14371618     Source Type: Journal    
DOI: 10.1007/s00481-010-0060-5     Document Type: Article

References (30)

1. Albisser Schlegel H, Pargger H, Reiter-Theil S (2008) "Futility" - Übertherapie am Lebensende? Gründe für ausbleibende Therapiebegrenzung in Geriatrie und Intensivmedizin. Z Palliativmed 9: 67-75.
2. Alpers A, Lo B (1995) When is CPR futile? JAMA 273: 156-158.
3. Beauchamp TL, Childress JF (2001) Principles of biomedical ethics, 5. Aufl. Oxford University Press, New York.
4. Bosshard G, Nilstun T, Bilsen J, Norup M, Miccinesi G, Delden JJ van et al (2005) Forgoing treatment at the end of life in 6 European countries. Arch Intern Med 165: 401-407.
5. Bundesärztekammer (2004) Dokumentation: Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung. Dtsch Arztbl 101(19): A-1298, B-1076, C-1040.
6. Craft PS, Burns CM, Smith WT, Broom DH (2005) Knowledge of treatment intent among patients with advanced cancer: a longitudinal study. Eur J Cancer Care (Engl) 14: 417-425.
7. Creswell JW (2003) Research design: qualitative, quantitative, and mixed methods approaches. Sage Publications, Thousand Oaks California.
8. Delden JJ van, Lofmark R, Deliens L, Bosshard G, Norup M, Cecioni R et al (2006) Do-not-resuscitate decisions in six European countries. Crit Care Med 34: 1686-1690.
9. Fallowfield L (2001) Participation of patients in decisions about treatment for cancer. BMJ 323: 1144.
10. Fojo T, Grady C (2009) How much is life worth: cetuximab, non-small cell lung cancer, and the $ 440 billion question. J Natl Cancer Inst 101: 1044-1048.
11. Gampel E (2006) Does professional autonomy protect medical futility judgments? Bioethics 20: 92-104.
12. Joralemon D (2002) Reading futility: reflections on a bioethical concept. Camb Q Healthc Ethics 11: 127-133.
13. Levinsky NG (1984) The doctor's master. N Engl J Med 311: 1573-1575.
14. Marckmann G (2003) Leitlinien zwischen Qualitätsverbesserung und Kostenkontrolle. In: Dietrich F, Imhoff M, Kliemt H (Hrsg) Standardisierung in der Medizin. Qualitätssicherung oder Rationierung? Schattauer, Stuttgart, S 237-252.
15. Neitzke G (2008) Unterscheidung zwischen medizinischer und ärztlicher Indikation - Eine ethische Analyse der Indikationsstellung. In: Charbonnier R, Dörner K, Simon S (Hrsg) Medizinische Indikation und Patientenwille. Schattauer, Stuttgart, S 53-66.
16. Pearson SD (2000) Caring and cost: the challenge for physician advocacy. Ann Intern Med 133: 148-153.
17. Pellegrino ED (2005) Futility in medical decisions: the word and the concept. HEC Forum 17: 308-318.
18. Reiter-Theil S (2004) Does empirical research make bioethics more relevant? "The embedded researcher" as a methodological approach. Med Health Care Philos 7(1): 17-29.
19. Sahm S (2008) Autonomie, ärztliche Indikation und Entscheidungsfindung. In: Charbonnier R, Dörner K, Simon S (Hrsg) Medizinische Indikation und Patientenwille. Schattauer, Stuttgart, S 123.
20. Schneiderman LJ, Jecker NS, Jonsen AR (1990) Medical futility: its meaning and ethical implications. Ann Intern Med 112: 949-954.
21. Schwappach DL, Koeck CM (2004) Preferences for disclosure: the case of bedside rationing. Soc Sci Med 59: 1891-1897.
22. Slevin ML, Stubbs L, Plant HJ, Wilson P, Gregory WM, Armes PJ et al (1990) Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 300: 1458-1460.
23. Splett T (2006) Was bedeutet eigentlich Patientenwille. In: Schildmann J, Fahr U, Vollmann J (Hrsg) Entscheidungen am Lebensende in der modernen Medizin: Ethik, Recht, Ökonomie und Klinik. LIT, Berlin, S 20.
24. Teno JM, Fisher ES, Hamel MB, Coppola K, Dawson NV (2002) Medical care inconsistent with patients' treatment goals: association with 1-year Medicare resource use and survival. J Am Geriatr Soc 50: 496-500.
25. The SUPPORT Principal Investigators (1995) A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 274: 1591-1598.
26. Truog RD, Brett AS, Frader J (1992) The problem with futility. N Engl J Med 326: 1560-1564.
27. Ubel PA, Arnold RM (1995) The unbearable rightness of bedside rationing. Physician duties in a climate of cost containment. Arch Intern Med 155: 1837-1842.
28. Voogt E, Heide A van der, Rietjens JA, Leeuwen AF van, Visser AP, Rijt CC van der et al (2005) Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol 23(9): 2012-2019.
29. Vos MS, Haes JC de (2007) Denial in cancer patients, an explorative review. Psychooncology 16: 12-25.
30. Winkler EC, Reiter-Theil S, Lange-Riess D, Schmahl-Menges N, Hiddemann W (2009) Patient involvement in decisions to limit treatment: the crucial role of agreement between physician and patient. J Clin Oncol 27: 2225-2230.